Patients included, follow-up years and age at inclusion stratified on country, gender and path_MMR variants
| Group | Sex | Cases | Follow-up years | Age at inclusion | |||||||
| Number | Mean | Min | Max | 95% CI | Mean | Min | Max | 95% CI | |||
| All | 3119 | 24 475 | 7.8 | 1 | 33 | ±0.2 | 43.8 | 25 | 79 | ±0.46 | |
| F | 1723 | 13 534 | 7.9 | 1 | 33 | ±0.26 | 44.6 | 25 | 79 | ±0.62 | |
| M | 1396 | 10 941 | 7.8 | 1 | 30 | ±0.29 | 42.9 | 25 | 79 | ±0.67 | |
| Country of origin | |||||||||||
| Finland | 952 | 9212 | 9.7 | 1 | 30 | ±0.38 | 43.2 | 25 | 79 | ±0.88 | |
| Denmark | 515 | 3084 | 6.0 | 1 | 17 | ±0.31 | 44.4 | 25 | 77 | ±1.09 | |
| UK | 386 | 2229 | 5.8 | 1 | 17 | ±0.4 | 45.7 | 25 | 79 | ±1.29 | |
| Norway | 294 | 2217 | 7.5 | 1 | 22 | ±0.61 | 44.7 | 25 | 79 | ±1.47 | |
| Spain | 202 | 1167 | 5.8 | 1 | 14 | ±0.51 | 47.6 | 25 | 75 | ±1.75 | |
| Germany | 179 | 1276 | 7.1 | 1 | 29 | ±0.76 | 43.5 | 25 | 72 | ±1.61 | |
| Holland | 165 | 898 | 5.4 | 1 | 28 | ±0.88 | 45.5 | 25 | 78 | ±2.00 | |
| Italy | 163 | 1773 | 10.9 | 1 | 33 | ±1.04 | 35.9 | 25 | 65 | ±1.42 | |
| Sweden | 159 | 1568 | 9.9 | 1 | 27 | ±0.88 | 44.7 | 25 | 77 | ±2.07 | |
| Australia | 104 | 1051 | 10.1 | 1 | 30 | ±1.35 | 39.2 | 25 | 70 | ±1.99 | |
| Gene | |||||||||||
| MLH1 | F | 781 | 7365 | 9.4 | 1 | 33 | ±0.41 | 42.9 | 25 | 79 | ±0.93 |
| M | 692 | 6481 | 9.4 | 1 | 30 | ±0.44 | 41.5 | 25 | 79 | ±0.96 | |
| MSH2 | F | 599 | 4233 | 7.1 | 1 | 30 | ±0.41 | 44.6 | 25 | 77 | ±1.02 |
| M | 461 | 3259 | 7.1 | 1 | 27 | ±0.45 | 42.2 | 25 | 73 | ±1.05 | |
| MSH6 | F | 276 | 1633 | 5.9 | 1 | 21 | ±0.49 | 48.7 | 25 | 79 | ±1.60 |
| M | 186 | 980 | 5.3 | 1 | 28 | ±0.61 | 46.8 | 25 | 79 | ±1.85 | |
| PMS2 | F | 67 | 303 | 4.5 | 1 | 20 | ±1.07 | 47.7 | 25 | 78 | ±2.73 |
| M | 57 | 221 | 3.9 | 1 | 22 | ±0.97 | 53.3 | 26 | 77 | ±3.59 | |